GSK Plc - HealthQuill

The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.

US regulator allows GSK’s endometrial cancer therapy for expanded use

The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.

by HealthQuill
August 4, 2024
0 Comments

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.

Drugs Health Pharma

GSK’s blood cancer test drug halves risk of disease progression: Data

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.

by HealthQuill
June 3, 2024
0 Comments

The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.

Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.

by HealthQuill
March 20, 2024
0 Comments

British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes medicines to treat asthma.

Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.

by HealthQuill
January 9, 2024
0 Comments

Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.

Drugs Health Medical Pharma

GSK’s Jemperli shows promise in treating endometrial cancer

HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.

by HealthQuill
October 30, 2023
0 Comments

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

Drugs Health Pharma

GSK Plc gets EU approval for HIV prevention drug Apretude

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

by HealthQuill
September 20, 2023
0 Comments

The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.

Drugs Health Pharma

USFDA gives nod for GSK’s Ojjaara bone cancer therapy

The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.

by HealthQuill
September 17, 2023
0 Comments

British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and tablets, cabotegravir, to prevent HIV.

Drugs Health Pharma

Britain’s GSK gets EMA clearance for drug to prevent HIV

HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.

by HealthQuill
July 24, 2023
0 Comments

British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.

Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.